Skip to main content
. 2021 Nov 22;126(3):440–448. doi: 10.1038/s41416-021-01624-2

Table 3.

Multivariate analysis of progression-free survival in the validation cohort.

Characteristic HRa 95% CIb P-value
WHO Performance status
   0 Ref
   1–2 1.43 0.98, 2.08 0.061
ctDNA
   ctDNA negative Ref
   ctDNA positive 1.50 1.03, 2.18 0.034
CA19.9_median
   ≤1366 Ref
   >1366 1.36 0.96, 1.92 0.085

Bold values indicate statistical significance p < 0.05.

Analysis was performed after stratification on studies and centers.

aHR Hazard ratio.

bCI confidence interval.